Jacob Lund, PhD (he/him/his)

Principal Scientist
Novo Nordisk
2860 Soeborg, Hovedstaden, Denmark

Jacob Lund, PhD. Principal Scientist in department of Rare Blood Disorders in Research and Early Development at Novo Nordisk A/S.
Biochemist by training, specialized in hemostasis biochemistry and interested in gene therapy. Early project manager and scientific coordinator. I am experienced in bi-specific antibodies, enzyme kinetics, computational modelling and data visualization among others.

Presentation(s):

• PB0156 - Higher Thrombin Generation Is Predicted When Switching Directly From Emicizumab to MIM8 in Patients With Hemophilia A

  Sunday, June 25, 2023
  18:30 – 19:30 ET